- Study protocol
- Open Access
Study protocol of “Worth the Walk”: a randomized controlled trial of a stroke risk reduction walking intervention among racial/ethnic minority older adults with hypertension in community senior centers
BMC Neurology volume 15, Article number: 91 (2015)
Stroke disproportionately kills and disables ethnic minority seniors. Up to 30 % of ischemic strokes in the U.S. can be attributed to physical inactivity, yet most Americans, especially older racial/ethnic minorities, fail to participate in regular physical activity. We are conducting a randomized controlled trial (RCT) to test a culturally-tailored community-based walking intervention designed to reduce stroke risk by increasing physical activity among African American, Latino, Chinese, and Korean seniors with hypertension. We hypothesize that the intervention will yield meaningful changes in seniors’ walking levels and stroke risk with feasibility to sustain and scale up across the aging services network.
In this randomized single-blind wait-list control study, high-risk ethnic minority seniors are enrolled at senior centers, complete baseline data collection, and are randomly assigned to receive the intervention “Worth the Walk” immediately (N = 120, intervention group) or in 90 days upon completion of follow-up data collection (N = 120, control group). Trained case managers employed by the senior centers implement hour-long intervention sessions twice weekly for four consecutive weeks to the intervention group. Research staff blinded to participants’ group assignment collect outcome data from both intervention and wait-list control participants 1 and 3-months after baseline data collection. Primary outcome measures are mean steps/day over 7 days, stroke knowledge, and self-efficacy for reducing stroke risk. Secondary and exploratory outcome measures include selected biological markers of health, healthcare seeking, and health-related quality of life. Outcomes will be compared between the two groups using standard analytic methods for randomized trials. We will conduct a formal process evaluation to assess barriers and facilitators to successful integration of Worth the Walk into the aging services network and to calculate estimated costs to sustain and scale up the intervention. Data collection is scheduled to be completed in December 2016.
If this RCT demonstrates superior improvements in physical activity and stroke knowledge in the intervention group compared to the control group and is found to be sustainable and scalable, Worth the Walk could serve as a primary stroke prevention model for racial/ethnic communities across the nation.
ClinicalTrials.gov NCT02181062; registered on June 30, 2014.
It is estimated that someone in the U.S. has a stroke every 40 sec and dies of one every 4 min . Racial/ethnic minorities are disproportionately affected by stroke [2, 3], with hypertensive older adults at particularly high risk [1, 4]. Stroke incidence among African Americans and Mexican Americans is higher than among non-Latino whites [1, 5]. African Americans, Latinos and Chinese Americans have higher incidence of hemorrhagic stroke than non-Latino whites . In the U.S., the relative risk of stroke mortality is up to 1.4 higher for Asians compared to non-Latino whites [7, 8]. African Americans , Latinos [10, 11], Chinese Americans  and Koreans  consistently report lower levels of knowledge about stroke and its risk factors. This knowledge gap is a likely contributing factor in observed stroke disparities and worse stroke outcomes for ethnic minorities.
Physical inactivity is a powerful modifiable risk factor for stroke and accounts for up to 30 % of population-attributable ischemic stroke risk in the U.S. [14, 15]. Regular physical activity has been associated with substantially lower stroke risk . Despite the empiric data supporting the benefits of exercise for stroke prevention and other health outcomes including mortality, over 30 % of Americans are physically inactive, with older adults and ethnic minorities being the least active groups [1, 17]. This suggests that there is a tremendous opportunity to reduce population stroke risk and decrease stroke disparities by increasing physical activity among ethnic minority seniors.
To this end, our UCLA scientists are working in close collaboration with the City of Los Angeles (L.A.) Department of Aging (DoA), a local Area Agency on Aging (AAA) overseen by the U.S. Administration for Community Living (ACL), to design, implement and test an effective sustainable program to increase physical activity and decrease stroke risk. Federal congressionally mandated Title III funds are distributed each year to AAAs that use this money to contract with local service providers (including a vast network of senior centers) to provide services to 3 million seniors annually . These services include but are not limited to assistance with meals, transportation, housing, safety and, increasingly, health promotion. Under the leadership of Dr. Kathy Greenlee, the U.S. ACL has advocated for the local AAAs to implement evidence-based health promotion programs such as the Chronic Disease Self- Management Program developed at Stanford University ; under the leadership of our collaborator General Manager Laura Trejo, the City of L.A. DoA has been a national leader in this effort to implement evidence-based programs.
Our team is currently testing the effectiveness of a culturally-tailored walking intervention called “Worth the Walk” (WTW) developed for African American, Latino, Chinese and Korean seniors on reducing physical inactivity. Our primary specific aim is: 1) to measure the effectiveness of the intervention in increasing walking levels (mean steps/day measured by pedometers) at the end of the 4 week intervention, and persistence after two months. We hypothesize that WTW will increase physical activity by increasing knowledge about stroke risk factors and improving self-efficacy for reducing stroke risk and being physically active. In addition to the primary study aim, the study has two sub-aims: 2) to explore the relationship between the intervention and biological markers of health including blood pressure, body-mass index, non-HDL cholesterol, glycosylated hemoglobin (HgA1c), and c-reactive protein (CRP); and 3) to examine the relationship between the intervention, self-efficacy, and healthcare seeking behaviors in order to best control stroke risk factors.
Worth the Walk was designed to be sustainable under routine (non-study) conditions, as it utilizes case managers who are already funded through the AAAs. Upon completion of this research study, we will have created a complete set of materials (training manuals, curricula, and accompanying materials) that AAAs across the nation can use to integrate the intervention into their own aging services networks. We will collect critical data on the delivery of WTW and its potential for sustainment and spread beyond the effectiveness trial period and participating sites, with the goal of facilitating its implementation into routine practice throughout the U.S.
This study is a single-blind randomized wait-list controlled trial. Participants are randomized within 4 ethnic-specific clusters at senior centers in Los Angeles to either immediate intervention or 3-month wait list (see Fig. 1). The intervention itself lasts 4 weeks. Measures are taken at baseline prior to randomization (T0), 1-month (T1—for the intervention arm, this is immediately following the 4-week intervention), and 3-months (T2—for the intervention arm, this is 2 months after completion of the intervention). Measures for control group participants are taken at the same time points (1 and 3-months after baseline) while they are still on the wait list; after 3-month data collection, all control arm participants are invited to participate in WTW but do not repeat outcome measures.
Community-based participatory research
This project has been designed and is conducted based on the principles of community-based participatory research, in which academic and community partners are equal members of the study team and participate together in shared decision making on the design, implementation, evaluation and dissemination of research findings . The Los Angeles Community Academic Partnership for Research in Aging (L.A. CAPRA) serves as the infrastructure for this bidirectional community-academic partnered research project. L.A. CAPRA is a collaboration between the University of California Los Angeles Division of Geriatrics and City of L.A. DoA. The L.A. CAPRA Community Action Board (CAB) motivated and guided the development of this project, identifying early on the need for a practical community-based stroke and physical activity program for older adults. The CAB worked closely with the study team to recruit laypersons and community representatives from each of the four targeted ethnic groups to serve on four ethnic-specific “mini-CABs” for the purposes of this project. The mini-CABs helped develop the intervention curriculum, iteratively reviewing drafts to ensure cultural specificity and sensitivity. Mini-CAB leaders also worked in close partnership with the UCLA-based team on all other project decisions including the recruitment and enrollment protocol, measurement selection, intervention design, and staff training.
Worth the Walk intervention: conceptual basis and development
The Worth the Walk intervention is culturally-tailored and based in social cognitive theory [21, 22] and attribution theory [23, 24]. It incorporates elements such as verbal persuasion, goal setting, problem solving, and attribution retraining techniques that encourage participants to modify their expectations for aging (i.e., teach older adults not to attribute mutable stroke risk factors to aging) and change their own behavior to reduce stroke risk. In a previous National Institute on Aging-funded RCT of a behavioral intervention to increase walking—¡Caminemos! (R01 AG024460-05) [25, 26]—our team enrolled 572 older Latinos from 27 community senior centers and randomized them to receive either an attribution retraining intervention teaching not to attribute sedentary lifestyle to old age, or an active control group (series of lectures). We followed participants for 24 months; the intervention successfully increased walking levels (mean increase 6207 steps/day) more than the control group (p = 0.04). Though this efficacy study succeeded in meaningfully increasing walking levels, the intervention delivery was supported by National Institutes of Health (NIH) funding of research staff, limiting the intervention’s sustainability. With the current effectiveness trial, we have adopted many components of the Caminemos intervention, linking them with stroke and stroke risk factor education to create a new culturally-tailored intervention, and have integrated the new intervention directly into senior center programming without relying on NIH-funded staff for implementation (essentially making the efficacy-to-effectiveness transition). Our study builds on the expertise our team acquired in conducting the Caminemos trial, including recruitment, retention, screening and enrollment protocols, pedometer training, and group leader training (see below).
The Worth the Walk intervention consists of a group-based facilitated curriculum with 8 sessions covering topics such as racial/ethnic disparities in stroke and stroke outcomes, what stroke risk factors and warning signs are, blood pressure control, and seeing a healthcare provider regularly. Sessions are 1 h in duration and occur twice weekly for 4 consecutive weeks at a designated senior center. Information in the curriculum on stroke risk factor knowledge is based on materials developed by the American Heart Association/American Stroke Association (AHA/ASA). Special emphasis is placed on physical activity because of its substantial contribution to stroke risk on a population basis . Walking is emphasized as an appealing physical activity based on its association with decreased morbidity and mortality among older adults  and the practical reality that walking is an accessible form of physical activity for most seniors.
Case manager group leaders provide verbal reinforcement of the concept that mutable risk factors for stroke such as sedentary lifestyle and high blood pressure should not be attributed to “old age,” and that all participants should expect to decrease their risk of stroke. At the end of alternating group sessions, group leaders encourage participants to set individualized verbal and written “promises” for improving their stroke risk factors – especially walking. Then, at the start of each subsequent group discussion session, participants are asked to report to the group: 1) the extent to which they met their personal promises; 2) whether there have been any difficulties in following through on their promises; 3) whether their beliefs about their ability to improve their stroke risk factors have changed since they started the program. Group leaders then provide positive encouragement and reinforce the message that controlling stroke risk factors should be an expected part of aging. Case manager group leaders also teach participants to identify the individual reasons why they might not always keep their stroke risk factor reduction promises, determine which reasons are mutable, and then “problem solve”  to identify solutions. For example, one reason for not reaching a walking goal could be that participants feel it is “too hot.” Though weather per se is not mutable, participants can come up with possible solutions to this problem, such as walking in the early morning, walking indoors at a shopping mall, etc. Problem-solving is generated from the group itself as much as possible; the role of the case manager group leaders is to help participants generate their own solutions. Knowledge, therefore, will be generated and conveyed within the group itself. It is also supplemented by comments from the case manager group leaders, who provide detailed instruction on how to improve stroke risk factors in the context of problem-solving exercises . Finally, participants are provided with a diary (adapted from AHA/ASA materials) where they are encouraged to record their daily physical activity. Participants experience performance accomplishment (internal positive reinforcement of behavior) when they follow through on their “promises” and observe themselves meeting their goals in their personal diaries.
To guide the development and cultural tailoring of WTW and ultimately enhance its acceptability, relevance, and impact, we conducted 12 focus groups with a sample of 132 African American, Latino, Chinese, and Korean seniors in Los Angeles prior to the trial. Based on these findings, culturally-specific beliefs about stroke and its risk factors were incorporated into the intervention curriculum using Hwang’s Formative Method for Adapting Psychotherapy (FMAP) . Operationalizing this framework allowed us to plan and document cultural adaptations to the curriculum in a systematic manner around the domains of cultural beliefs, curriculum/intervention orientation, participant-moderator relationship, and cultural issues of salience. Sessions 6 and 7 of the curriculum were specifically tailored for each of the four targeted ethnic groups and contain different subject matter based on the focus group data; for example, African American sessions 6 and 7 are entitled “Walking is Good for the Body (and Relieving Stress)” and “Walking is Good for the Soul,” respectively, while for Chinese Americans they are entitled “The ‘3 Highs’: High Blood Pressure, High Cholesterol, High Fat” and “Family Matters.” The 4 ethnic-specific mini-CABs iteratively modified the intervention to increase its likelihood of resonating with targeted end users and also advised on how its relevance and impact could be improved overall.
Prior to intervention implementation, all case managers completed an intensive 2-day training session led by the study team during which ethnic-specific versions of the curriculum and an overview of the study design were covered. Two case managers were trained per site. Certificates of completion were distributed at the conclusion of the training when case managers were able to successfully lead an observed mock session and demonstrate their ability to teach the content accurately.
To maximize the sustainability of the intervention and achieve effectiveness research conditions, we integrated the WTW intervention into existing programming at 4 senior centers in Los Angeles. Los Angeles is an ideal place to conduct this study, not only because of its exceptional aging services network, but also because of its extraordinary ethnic diversity and leadership in the U.S. sociodemographic shift towards non-majority race being the norm. Los Angeles is home to large populations of three of the fastest growing demographic groups of older Americans: Latinos, Chinese Americans and Korean Americans, who together comprise over 50 % of the total population in Los Angeles County (ethnic-specific populations as a whole, not just those aged 65 years and older) .
Participants – inclusion and exclusion criteria
We are enrolling an eventual total of 240 participants (60 participants from each of the 4 targeted ethnic groups). Eligibility criteria include: 1) age 60 years or older; 2) self-identifying as the racial/ethnic group for the intervention planned at that site (African American, Latino, Chinese, or Korean); 3) ability to communicate verbally in the appropriate language (English, Spanish, Mandarin, or Korean) in a group setting; 4) ability to sit in a chair and participate in a 1 h discussion session; 5) ability to walk with or without the use of assistive devices such as canes and walkers; 6) available to attend the baseline data collection session and subsequent weekly intervention sessions; 7) has been told by a health care provider that s/he has high blood pressure; 8) able/willing to provide the name of a physician who has seen the potential participant in the past 6 months and provide signed consent for our staff to contact this physician; 9) plans to continue to live in the region during the next 6 months; and 10) cognitive capacity to provide informed consent to participate. Potential participants whose physicians fax a reply card indicating medical contraindication are not eligible (see below under Study procedures, Recruitment section). Potential participants whose physicians fax a reply card indicating no contraindication or do not respond within one week are eligible.
Recruitment, screening, enrollment, baseline
Recruitment takes place at the same 4 senior centers (one for each ethnic group) where in-house WTW case managers have been trained. Members of the research team make brief presentations describing the project during events attended by large numbers of seniors, such as the low-cost hot midday meals provided at all of the senior centers participating in this study. Recruitment flyers our team developed in partnership with our mini-CABs listing the study objectives, eligibility criteria, and staff contact information are also posted and distributed at senior center sites. Potentially eligible seniors are invited to approach/contact study staff individually to be formally screened on pre-determined days at the senior center.
During screening, study staff complete in face-to-face format a screener form listing the eligibility criteria with each prospective participant. Prospective participants are given a FITBIT® Zip pedometer and instructed on its proper use. A letter and reply form (referenced above) is then faxed to the physician indicated by each potentially eligible participant (along with the patient’s signature indicating consent for our staff to contact the physician) describing the intervention and asking him or her to contact the study team within one week stating whether his or her patient has any medical contraindication to participating, including unstable angina, uncompensated heart failure, uncontrolled cardiac arrhythmia, severe aortic stenosis, hypertrophic cardiomyopathy, cardiomyopathy from recent myocarditis, severe pulmonary hypertension, abdominal aortic aneurysm, recent systemic or pulmonary embolus, thrombophlebitis, and severe balance problems. A faxable reply form is provided so that the physician can simply check “yes” or “no.”
Approximately one week after screening has been completed, eligible participants are invited to attend a baseline data collection session at the senior center, during which trained project staff complete the informed consent process with each potential participant individually in a private setting. After participants have provided written documentation of informed consent, staff proceed to collect baseline data (see Table 1).
Randomization & blinding
After baseline data have been collected and participants have dispersed, we utilize a computerized randomization procedure stratified by site and gender to assign participants to either the intervention or the control (wait-list) arm. The randomization procedure is programmed into Research Electronic Data Capture (REDCap), a secure web application for building and managing online surveys and databases . A randomization allocation table was created using random permuted blocks with randomized block sizes 2, 4, 6 and is uploaded into REDCap. Smaller block sizes are used to distribute participants within either group as evenly as possible.
One designated research assistant is un-blinded for the duration of the study and works with senior center staff to schedule the WTW intervention sessions. Senior center staff call participants to inform them of their scheduled intervention session. While the case manager group leaders administer WTW, the same un-blinded research assistant attends sessions to take attendance and monitor fidelity to the curriculum using a standardized checklist of all the major teaching points of each intervention session (see Additional file 1: Appendix A). Other (blinded) project staff members maintain regular telephone contact with participants in both arms of the study to remind them to wear their pedometers but without explicitly prompting physical activity or walking. Project staff who are in the field collecting data are blinded to the participant assignment group for the entire study duration.
All participants in both the intervention and control groups receive the same frequency of contact from study staff (phone call reminders) and the same incentives (pedometers, $25 visa gift card at each data collection time point). We do not refer to the control group as a “wait-list” when speaking with participants and agency staff, but rather refer to that group by the month in which they will start the WTW program, for example, we will compare the “January” group with the “April” group.
Participants assigned to the intervention group immediately attend the group-based interactive behavioral stroke risk reduction walking intervention led by an in-house case manager after baseline (T0). In addition to reminder phone calls prior to each intervention session, efforts to increase retention and sustain participation in the intervention include scheduling transportation for participants when applicable, as well as notifying participants that attendance will be taken at each session.
Wait-list control group
Participants assigned to the wait-list control group are invited to participate in WTW after follow-up data collection is completed 3 months from baseline (they do not repeat outcome measures at this time). As previously mentioned, control group participants are also given pedometers by blinded RAs, receive the same reminders to wear them, have follow-up data collected at the same time points, and have the same frequency of contact with study personnel as the intervention group throughout the study duration.
Data sources include FITBIT® Zip pedometers , surveys, physical exams, and fingerpricks. The surveys, physical exams, and fingerpricks are administered with each individual at the senior centers by trained bilingual study staff. Surveys are interviewer-administered using REDCap , accessed using iPads with internet access. Survey instruments were translated into the native languages of our targeted ethnic groups (Spanish, Mandarin and Korean) a priori through a professional translation company; the accuracy of translations was verified by bilingual study staff as well as by seniors with whom the surveys were piloted prior to trial implementation. Pedometer data are downloaded using the iPads and stored/accessed through the secure FITBIT® website at each data collection time point. All study outcomes, collection time points, and data sources are listed in Table 1.
The primary outcome measure is change in walking level from baseline (T0) to 1 and 3 months (T1 and T2) as measured by the FITBIT® Zip pedometers. Physical activity level is supplementarily assessed using the International Physical Activity Questionnaire  included in the survey at all three time points. Stroke risk factor knowledge is assessed via survey using the Stroke Action Survey and questions developed by Pancioli et al. [35, 36]. We measure self-efficacy for reducing stroke risk and increasing physical activity. Self-efficacy is best captured by measuring both self-efficacy expectations and outcome expectations . As such, we measure self-efficacy expectations with the General Self-Efficacy Scale  and a modified version of the Chronic Disease Self-Efficacy Scale  that focuses on self-efficacy for stroke risk reduction; outcome expectations for being physically active is assessed using the Outcome Expectations for Exercise Scale .
To explore the relationship between the intervention and biological markers of health, we collect height and weight in light clothing without shoes at all three data collection time points in strict accordance with standardized procedures we have used previously. A random 5 % of participants will have their weight and height measured by two different research assistants so that inter-rater reliability can be calculated. To assess our main secondary outcome measure—systolic blood pressure—trained staff implement a standard, seated blood pressure protocol based on current Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines, but allowing a 5-min rest between each measure . Point-of-care CardioChek meters are used to measure cholesterol (using the Lipid Panel strip), which require only a small capillary blood sample (from a fingerprick). We use dried blood spots to obtain assays for HgA1c and CRP, also collected by fingerpricks. So that we can explore whether the intervention influenced healthcare seeking to control stroke risk factors, we ask participants to report on visits to healthcare providers in the previous three months at baseline and 3 months .
Other exploratory outcomes and covariates
Other measures being collected are listed in Table 1. These include exploratory outcomes that might be influenced by the intervention such as health-related quality of life  and stress . In addition, we will measure constructs such as acculturation level  and neighborhood walkability  that, while not linked explicitly to specific aims, are considered to be critical covariates likely to be associated with outcomes and can also be used to evaluate the success of the randomization.
Sample size and power
As described above, our primary outcome of interest is change in mean steps/day, while our main secondary outcome measure is change in systolic blood pressure. Based on our capacity, we plan to enroll 240 subjects from 4 senior centers. From our previous senior center research we estimate that as many as 15 % of subjects will not complete follow-up. Data from our previous senior center studies of older Latinos and African Americans showed mean steps/day 2713 (std. dev. 2190) and mean SBP 141 mm Hg (std. dev. 20 mm Hg); intra-class correlation within senior centers was at 0.0085. Since we propose a repeated measures design with 3 repeated measurements , the underlying statistical power of the study comes from two dimensions of observations: the number of unique subjects and the number of repeated measurements within a subject. Based on sample size/power analytic methods for repeated measures analysis [47, 48], using a 2-sided test with a type I error of 0.05, and a type II error of 0.2 (power 80 %), and assuming an average 2.7 data points per subject and an auto-correlation at 0.2 level, after adjusting for clustering, the effective sample size will be 96 subjects in each arm, which will enable us to detect effect sizes as small as 581 steps/day (far below a clinically meaningful increase of 5000 steps/day ) and 5.3 mm Hg. A decrease of 5 mm Hg substantially decreases stroke risk  and is comparable to effect sizes observed in walking interventions of similar intensity .
Overview of analytic plan
We will use standard analytic methods for randomized controlled trials . After comparing baseline characteristics of intervention and control group participants, and accounting for missing data, outcomes will be compared between the two groups. Though we have made unidirectional hypotheses, to allow for the chance that participants enrolled to the control group could have better outcomes than those in the intervention arm, we will use 2-tailed tests of significance for all analyses.
Multiple comparisons 
We have a priori selected the outcome of change in steps/day to be the primary endpoint of interest. Analyses of all other outcomes will be adjusted for multiple comparisons .
Intention to treat
All analyses will be conducted using intention to treat, in which any subject randomized to the intervention arm remains in that arm regardless of whether or not he or she received the intervention, and likewise for the control arm. We will measure level of participation for those randomized to the intervention arm, and will conduct a sensitivity analysis that assesses the stability of the study’s conclusions when an intention to treat analysis versus an analysis that takes into account level of participation in the intervention.
Comparing baseline characteristics of intervention and control arm subjects
Using t-tests for continuous variables and chi-square tests for categorical variables, we will compare the two groups on baseline characteristics to measure the success of the randomization: 1) sociodemographic characteristics; 2) mean steps/day over 1 week in the window post screening and distribution of pedometers, to the T0 baseline data collection one week later; 3) systolic blood pressure, body mass index, non-HDL cholesterol, HgA1c; 4) stroke knowledge, self-efficacy. Since steps/day is a continuous variable, at each time-point (30 days/T1 and 90 days/T2) we will perform a simple descriptive cross-sectional analysis of mean change in scores between baseline and follow-up in each treatment arm. In our primary analyses, we will test the statistical significance of the unadjusted difference in change-scores between the groups using t-tests for symmetrically distributed data and analogous nonparametric tests such as the Wilcoxon sign rank tests for data that are skewed. Imbalance between the treatment arms of characteristics described above would inflate the standard error, making the unadjusted analyses appropriately conservative; therefore, the unadjusted analyses will serve as the primary results of the trial. If, however, we did identify chance differences between the treatment arms in the distribution of the baseline level of the outcome, then we will also conduct secondary analyses in which we will use multivariate modeling, such as analysis of covariance, to adjust for these factors. The adjusted means of the change-scores from multivariate models will be compared and tested between the two arms, and will also be compared with the unadjusted means to assess the influence of these factors on endpoints. As sensitivity analyses, we will also examine the difference between groups in the absolute steps/day (instead of the change-score), adjusting for baseline. These sensitivity analyses will allow us to compare outcomes between groups without assuming linearity of effect across different baseline levels of physical activity. Using multivariate modeling, we will also test interactions between treatment arm and selected effect modifiers (e.g., age, level of acculturation, etc.) to identify sub-groups of participants who improve more than other groups. Since this trial is not designed with power to examine these subgroups, these analyses will be exploratory and hypothesis-generating in nature. Finally, we will assess changes in steps/day between baseline and the end of the intervention period, and differences between the control and intervention groups in steps/day trajectories over time. These analyses will consist of graphical analysis and parametric statistical testing using repeated measures mixed effects models [55, 56]. To determine the extent to which increases in stroke knowledge and self-efficacy mediate improvements in steps/day, the variation (R-squared) in increase in steps/day is explained by variation in increase in the stroke knowledge and self-efficacy constructs will be calculated [57, 58]. Analysis of the effect of the intervention on all the secondary and exploratory outcomes will follow the same analysis.
We will examine the variation in effectiveness of the intervention among the 4 sites and will conduct a formal process evaluation to: 1) determine general and site-specific factors associated with greater effectiveness; 2) assess the feasibility, acceptability, and sustainability of the intervention; 3) measure the costs needed to implement and maintain the intervention. We will meet separately with key stakeholders at each site including seniors (RCT participants), case manager group leaders, senior center directors, other senior center staff involved in implementing the program (for example the staff members who set the schedules at the senior centers), and 2–3 healthcare providers involved in the enrollment screening process for participants at each site. In semi-structured interviews guided by previous successful implementation analyses [59, 60] we will ask questions such as: What was your role in the intervention and what outcomes did you seek to achieve? How was the intervention received by you and others in your site and did this change over time? What are the potential barriers and facilitators to implementing the intervention outside of the research study? What problems were associated with delivering the intervention and how might they translate (or not) into “real-world” implementation beyond the study trial (NIH grant) period? How did this program affect workload, burden and space? What potential modifications to the intervention could be made to maximize implementation? How (if at all) did this program change your relationship with the healthcare/senior center community? Transcripts will be read by 2 investigators who will use previously-described content analysis methods [60, 61] to identify behaviors, attitudes, personal characteristics, contexts, processes, and policies the informants believed to be associated with the implementation and sustainability of the intervention. Start-up costs needed to implement the intervention (such as items required for group leader training) will be tracked and recorded.
Results from this trial will provide important insight into the design and effectiveness of sustainable community-based interventions aiming to reduce stroke risk and mitigate disparities among hypertensive ethnic minority seniors. We have combined two different theories from motivational psychology with an extensive body of stroke education using materials from the AHA/ASA to develop a culturally-tailored intervention that has been directly integrated into the aging services network in Los Angeles. The demographic composition of Los Angeles is representative of projected trends for the nation; therefore, culturally-tailored projects that succeed in Los Angeles are natural models to take to scale nationally.
We recognize that a major disadvantage to using a wait-list control rather than an active simultaneous control is that participants are not blinded to whether or not they are receiving the intervention and thus may have different expectations of improvement during the data collection period. In other words, participants in the intervention arm might improve just because they know they are in the intervention arm rather than from the content of the intervention (and conversely those on the wait list might show little improvement because they know they are not “supposed” to improve while on the wait list). In addition, there could be disproportionate follow-up between study arms as wait-list participants move away or lose interest that could bias the study findings. Alternatively, participants randomized to the wait list control arm could seek their own plan to prevent stroke risk outside of the intervention, contaminating the control arm.
Nevertheless, given the strong level of enthusiasm by senior center leaders and clients (seniors) for this type of intervention, it is not feasible to have a blinded control arm within a single senior center; this would be perceived as unfair and generating ill-will among the senior center attendees. To minimize the effect of non-blinding on the study design, we ensure that all participants receive the same frequency of contact from study staff in terms of phone call reminders and incentives including pedometers.
Though multifaceted (including both formal stroke education and behavioral change strategies), this intervention is intentionally designed to be low-cost, sustainable and scalable. We chose to use in-house AAA-funded case managers rather than professional healthcare providers because a major goal of this project is to evaluate a practical and sustainable intervention that can be scaled up across the national aging services network; thus, even a modest stroke risk factor reduction in physical activity or blood pressure could have a tremendous population impact on preventing strokes and decreasing stroke disparities. Upon completion of this trial, we will have trained a cadre of senior-center based case managers in a new skill set of health disparities intervention implementation that can be used not only for stroke risk factor reduction interventions but also other evidence-based health promotion programs.
Randomized controlled trial
Department of aging
Area agency on aging
Administration for community living
Worth the Walk
- L.A. CAPRA:
Los Angeles community academic partnership for research in aging
Community action board
National institutes of health
American heart association/American stroke association
Formative method for adapting psychotherapy
Research electronic data capture
Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
Cruz-Flores S, Rabinstein A, Biller J, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(7):2091–116.
Attenello F, Adamczyk P, Wen G, He S, Zhang K, Russin J, et al. Racial and socioeconomic disparities in access to mechanical revascularization procedures for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(2):327–34.
Five-year strategic plan on minority health disparities. [http://www.ninds.nih.gov/about_ninds/plans/disparities.htm].
Morgenstern L, Smith M, Lisabeth L, Risser J, Uchino K, Garcia N, et al. Excess stroke in Mexican Americans copmpared with non-Hispanic whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004;160(4):376–83.
Qureshi A, Mendelow A, Hanley D. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632–44.
Deaths: Final Data for 2013. [http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf].
US Department of Health and Human Services CfDCaP. Age-specific excess deaths associated with stroke among racial/ethnic minority populations– United States, 1997. MMWR Morb Mortal Wkly Rep. 2000;49(5):94–7.
Fussman C, Rafferty A, Reeves M, Zackery S, Lyon-Callo S, Anderson B. Racial disparities in knowledge of stroke and heart attack risk factors and warning signs among Michigan adults. Ethn Dis. 2009;19(2):128–34.
Goldstein L, Silberberg M, McMiller Y, Yaggy S. Stroke-related knowledge among uninsured Latino immigrants in Durham County, North Carolina. J Stroke Cerebrovasc Dis. 2009;18(3):229–31.
Christian A, Rosamond W, White A, Mosca L. Nine-year trends and racial and ethnic disparities in women’s awareness of heart disease and stroke: an American Heart Association national study. J Womens Health. 2007;16(1):68–81.
Ton T, Steinman L, Yip M-P, Ly K, Sin M-K, Fitzpatrick A, et al. Knowledge of cardiovascular health among Chinese, Korean and Vietnamese immigrants to the US. J Immigr Minor Health. 2011;13(1):127–39.
Hwang S, Zerwic J. Knowledge of stroke symptoms and risk factors among Korean immigrants in the United States. Res Nurs Health. 2006;29(4):337–44.
Goldstein L, Bushnell C, Adams R, Appel L, Braun L, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517–84.
Willey J, Moon Y, Paik M, Boden-Albala B, Sacco R, Elkind M. Physical activity and risk of ischemic stroke in the Northern Manhattan Study. Neurology. 2009;73(21):1774–9.
O’Donnell M, Xavier D, Liu L, Zhang H, Chin S, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case–control study. Lancet. 2010;376(9735):112–23.
Schoenborn C, Adams P, Peregoy J. Health behaviors of adults: United States, 2008–2010. In: Statistics NCfH, editor. Vital Health Stat. 2013.
Aging Ao. Justification of Estimates for Appropriations Committee: Health and Human Services. 2012. p. 22.
Lorig K, Ritter P, Stewart A, Sobel D, William Brown BJ, Bandura A, et al. Chronic Disease Self-Management Program: 2-Year health status and health care utilization outcomes. Med Care. 2001;39(11):1217–23.
Norris K, Brusuelas R, Jones L, Miranda J, Duru K, Mangione CM. Partnering with community based organizations: an academic institution’s evolving perspective. Ethn Dis. 2007;17(1 Suppl 1):S27–32.
Bandura A. Self-efficacy: The exercise of control. New York: W.H. Freeman and Company; 1997.
Bandura A. Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
Weiner B. An attributional theory of achievement motivation and emotion. Psychol Rev. 1985;92(4):548–73.
Forsterling F. Attribution: An Introduction to Theories. Research and Applications London: Press Ltd.; 2001.
Sarkisian CA, Prohaska TR, Davis C, Weiner B. Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults. J Am Geriatr Soc. 2007;55(11):1842–6.
Sarkisian CA TL, Wang P, Frank J, Weiner B. Caminemos! A randomized trial of a behavioral intervention to increase walking among sedentary older Latinos. J Am Geriatr Soc. 2010;58(Supplement S1):S15.
LaCroix A, Leveille S, Hecht J, Grothaus L, Wagner E. Does walking decrease the risk of cardiovascular disease hospitalizations and death in older adults? J Am Geriatr Soc. 1996;44(2):113–20.
Clark NM, Janz NK, Dodge JA, Sharpe PA. Self-regulation of health behavior: the “take PRIDE” program. Health Educ Q. 1992;19(3):341–54.
Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl IH, Blair SN. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: A randomized trial. JAMA. 1999;281(4):327–34.
Hwang W-C. The Formative Method for Adapting Psychotherapy (FMAP): A community-based developmental approach to culturally adapting therapy. Prof Psychol Res Pract. 2009;40(4):369–77.
State and County QuickFacts: Los Angeles County, California. [http://quickfacts.census.gov/qfd/states/06/06037.html].
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
Tully M, McBride C, Heron L, Hunter R. The validation of Fitbit Zip physical activity monitor as a measure of free-living physical activity. BMC Res Notes. 2014;7:952.
Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport. 2000;71(2 Suppl):S114–20.
Billings-Gagliardi S, Mazor K. Development and validation of the stroke action test. Stroke. 2005;36(5):1035–9.
Pancioli A, Broderick J, Kothari R, Brott T, Tuchfarber A, Miller R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA. 1998;279(16):1288–92.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Measures in Health Psychology: A User’s Portfolio Casual and Control Beliefs, vol. 1. Windsor, UK: NFER-NELSON; 1995. p. 35–7.
Lorig K, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome Measures for Health Education and other Health Care Interventions. Thousand Oaks, CA: Sage Publications; 1996.
Resnick B, Zimmerman S, Orwig D, Furstenberg A, Magaziner J. Outcome expectations for exercise scale: utility and psychometrics. J Gerontol B Psychol Sci Soc Sci. 2000;55(6):S352–6.
Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.
Ritter P, Stewart A, Kaymaz H, Sobel D, Block D, Lorig K. Self-reports of health care utilization compared to provider records. J Clin Epidemiol. 2001;54(2):136–41.
Ware JJ, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.
Ryder A, Alden L, Paulhus D. Is acculturation unidimensional or bidimensional? A head-to-head comparison in the prediction of personality, self-identity, and adjustment. J Pers Soc Psychol. 2000;79(1):49–65.
Cerin E, Saelens B, Sallis J, Frank L. Neighborhood Environment Walkability Scale: validity and development of a short form. Med Sci Sports Exerc. 2006;38(9):1682–91.
Brown H, Prescott R. Applied Mixed Models in Medicine. 2nd ed. Chichester, West Sussex, England: John Wiley & Sons Ltd.; 2006.
Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1994.
Liu H, Wu T. Sample size calculation and power analysis of time-averaged difference. J Mod Appl Stat Method. 2005;4(2):434–45.
Tudor-Locke C, Bassett DJ. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med. 2004;34(1):1–8.
Sacco R, Boden-Albala B, Abel G, Lin I, Elkind M, Hauser W, et al. Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke. 2001;32(8):1725–31.
Duru OK, Sarkisian CA, Leng M, Mangione CM. Sisters in motion: a randomized controlled trial of a faith-based physical activity intervention. J Am Geriatr Soc. 2010;58(10):1863–9.
Friedman L, Furberg C. DeMets D: Fundamentals of Clinical Trials. Littleton, Mass: PSG Publishing Company Inc.; 1985.
Tukey J. Some thoughts on clinical trials, espeically problems of multiplicity. Science. 1977;198:679–84.
Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol. 1998;25(12):1032–7.
McCullagh P, Nelder J. Generalized Linear Models. 2nd ed. New York: Chapman & Hall; 1989.
McCulloch C, Searle S. Generalized, Linear, and Mixed Models. New York: Wiley; 2001.
Mackinnon D, Dwyer J. Estimating mediated effects in prevention studies. Eval Rev. 1993;17(2):144–58.
Baron R, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26. epub ahead of print.
Curran G, Sullivan G, Mendel P, et al. Implementation of the CALM intervention for anxiety disorders: a qualitative study. Implement Sci. 2012;7(1):14.
Weber R. Basic Content Analysis. SAGE: Beverly Hills, CA; 1990.
This work was supported by the National Institute of Neurological Disorders and Stroke [1U54NS081764] and the National Institute on Aging [1K24AG047899-01]. Additional sources of support for this project include the National Institute on Aging UCLA Older Americans Independence Center [P30AG028748] and National Institute on Aging Resource Centers for Minority Aging Research IV/Center for Health Improvement of Minority Elderly III ( P30AG021684).
The authors declare that they have no competing interests.
IK participated in data collection and project planning—including development of the enrollment and data collection protocol, survey, and curriculum—and led the drafting of the manuscript. SC participated in data collection and assisted with the cultural tailoring of the intervention. BM participated in the design of the study and led the development of the formal process evaluation. NB made significant contributions to the cultural tailoring of the intervention. HL participated in the design of the study and led the development of the analysis plan. BV contributed to the conception and design of the study. SS contributed to the design of the study and curriculum. DA participated in study implementation, including data collection and case manager training. HM and TS contributed to the design of the study and designed the protocol for obtaining, storing and analyzing all indicated biomarkers. SO made contributions to the development and cultural tailoring of the intervention. LT contributed to the conception and design of the study and facilitated access to senior center sites. CS led development of the study design and implementation, has full access to the data, and takes responsibility for the integrity and accuracy of the analysis. All authors read and contributed to the preparation of the manuscript.
About this article
Cite this article
Kwon, I., Choi, S., Mittman, B. et al. Study protocol of “Worth the Walk”: a randomized controlled trial of a stroke risk reduction walking intervention among racial/ethnic minority older adults with hypertension in community senior centers. BMC Neurol 15, 91 (2015). https://doi.org/10.1186/s12883-015-0346-9
- Ethnic minority
- Primary prevention
- Behavioral intervention
- Clinical trial